Dose-dependent pharmacokinetics of cyclosporin a in rats: Events in tissues

被引:0
|
作者
Tanaka, C
Kawai, R
Rowland, M
机构
[1] Novartis Pharma AG, Drug Metab & Pharmacokinet, CH-4002 Basel, Switzerland
[2] Novartis Pharmaceut Corp, Drug Metab & Pharmacokinet, E Hanover, NJ USA
[3] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclosporin A (CyA) tissue distribution kinetics was extensively studied after single 1.2-, 6-, and 30-mg/kg CyA doses (via 2-min i.v. infusion) to rats. Drug concentrations in blood and various tissues were measured using a specific radioimmunoassay. Based on total blood concentration data alone, CyA systemic pharmacokinetics appeared essentially linear. However, after taking the saturable, nonlinear blood cell binding into account, multiple nonlinear factors were identified. Intrinsic clearance at 30 mg/kg was about half the value at the two lower doses. Tissue distribution was also dose-dependent, with evidence of saturable binding in many tissues. In general, blood binding saturation (dissociation constant K-D = 0.18 mu g/ml) occurred at a lower dose (concentration) than saturation of tissue binding (K-D, 0.005-0.77 mg/g), such that the volume of distribution at steady state first increased as the dose increased from 1.2 to 6 mg/kg, and then decreased as the dose increased to 30 mg/kg. Tissue binding was further investigated by various graphical analyses. Some organs showed a monophasic (single site) Scatchard plot of the tissue data at steady state, with high K-D values. In other organs, biphasic binding characteristics were observed with the K-D values of the high-affinity site in the same range as the K-D reported for the binding of CyA with cyclophilin, the putative target. Saturable tissue binding may therefore influence not only the pharmacokinetics but also the efficacy of CyA.
引用
收藏
页码:582 / 589
页数:8
相关论文
共 50 条
  • [1] DOSE-DEPENDENT PHARMACOKINETICS OF MEZLOCILLIN IN RATS
    JUNGBLUTH, GL
    JUSKO, WJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 839 - 843
  • [2] Dose-dependent pharmacokinetics of bulleyaconitine A in rats
    Xu, H. R.
    Ji, G. X.
    Wang, Q.
    Li, X. N.
    Gong, Y. J.
    Zhang, Y.
    Li, W.
    Shen, T.
    PHARMAZIE, 2013, 68 (03): : 170 - 172
  • [3] DOSE-DEPENDENT PHARMACOKINETICS OF GLYCYRRHIZIN IN RATS
    ISHIDA, S
    SAKIYA, Y
    ICHIKAWA, T
    TAIRA, Z
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (07) : 1917 - 1920
  • [4] EVIDENCE FOR A POSSIBLE DOSE-DEPENDENT PHARMACOKINETICS OF CYCLOSPORIN-A IN THE RAT
    NOOTER, K
    SCHULTZ, F
    SONNEVELD, P
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1984, 43 (03): : 407 - 415
  • [5] APPARENT DOSE-DEPENDENT ORAL ABSORPTION OF CYCLOSPORIN A IN RATS
    UEDA, CT
    LEMAIRE, M
    GSELL, G
    MISSLIN, P
    NUSSBAUMER, K
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (02) : 141 - 151
  • [6] DOSE-DEPENDENT PHARMACOKINETICS
    VANROSSUM, JM
    VANLINGEN, G
    BURGERS, JPT
    PHARMACOLOGY & THERAPEUTICS, 1983, 21 (01) : 77 - 99
  • [7] Dose-Dependent Pharmacokinetics of SP-8203 in Rats
    Lee, Joo H.
    Choi, Young H.
    Suh, Jung H.
    Kang, Hee E.
    Lee, Tae H.
    Cho, Il H.
    Lee, Myung G.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2010, 31 (5-6) : 358 - 361
  • [8] DOSE-DEPENDENT PHARMACOKINETICS OF PREDNISOLONE IN NORMAL AND ADRENALECTOMIZED RATS
    BOUDINOT, FD
    JUSKO, WJ
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1986, 14 (05): : 453 - 467
  • [9] DOSE-DEPENDENT PHARMACOKINETICS OF ENPROFYLLINE AND ITS RENAL HANDLING IN RATS
    NADAI, M
    HASEGAWA, T
    MURAOKA, I
    TAKAGI, K
    NABESHIMA, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (07) : 648 - 652
  • [10] DOSE-DEPENDENT PHARMACOKINETICS OF DEXAMETHASONE
    LOEW, D
    SCHUSTER, O
    GRAUL, EH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (02) : 225 - 230